[Comparative evaluation of the long-term results of treatment of cervical cancer using radiocolloids].

The author provided a comparative analysis of the results of therapy of 127 cervical cancer patients. 198Au-(75 patients) and 90Y-colloids (52 patients) were administered intraparametrially for adjuvant radiotherapy. The summary absorbed dose in combined modality radiation therapy was 90-100 Gy at the point A and 40-50 Gy at the point B. The author presented 5- and 10-year survival rates which were higher with 90Y-colloid as compared to those with 198Au-colloid. Early radiation reactions and late radiation injuries developed somewhat more frequently with 90Y. However statistical differences were insignificant. Thus, combined modality radiation therapy of cervical cancer using 90Y-colloid for adjuvant radiotherapy considerably enhances therapeutic efficacy without increasing the number of radiation complications.